Press "Enter" to skip to content

New patent expiration for Pf Prism drug BOSULIF


Annual Drug Patent Expirations for BOSULIF
Annual Drug Patent Expirations for BOSULIF

Bosulif is a drug marketed by Pf Prism Cv
and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has forty-one patent family members in twenty-eight countries.

The generic ingredient in BOSULIF is bosutinib monohydrate. Two suppliers are listed for this compound. Additional details are available on the bosutinib monohydrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

    Do NOT follow this link or you will be banned from the site!